Pyramid Altoona Outpatient

Pyramid Altoona Outpatient is an addiction-treatment facility located in Altoona, PA. The facility offers a continuum of care across multiple levels — PHP, IOP, MAT — which means it can, in principle, hold a patient across the arc of a typical treatment episode. What follows is an orientation — not a review — to the practical questions worth asking before admission.

Care levels at Pyramid Altoona Outpatient

The facility offers a continuum of care across multiple levels — PHP, IOP, MAT — which means it can, in principle, hold a patient across the arc of a typical treatment episode. The practical question is whether it is genuinely strong at each level, or whether one level is the core business and the others are secondary. The useful move is to have an ASAM-aligned assessment done before admission — ideally by someone outside the facility's admissions team — to confirm that the level of care offered here is what the clinical picture calls for.

Insurance and payment

On insurance specifically: Pyramid Altoona Outpatient accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. Before admission, ask the facility's utilization-review team for a written Verification of Benefits — not verbal assurance, which is where most post-treatment financial surprises come from. Also ask for specific plan-level confirmation, not carrier-level (e.g., "your Aetna PPO plan" not just "Aetna").

Before you call

Before admission to Pyramid Altoona Outpatient, three questions consistently produce the most useful information: (1) which ASAM level of care are you treating me at, and what is the clinical rationale; (2) can you send me a written Verification of Benefits for my specific insurance plan; (3) what is your policy on medication-assisted treatment for opioid use disorder — specifically, do you continue patients on buprenorphine or methadone during residential programming. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.